Results

Total Results: 292 records

Showing results for "bone".
Users also searched for: bone density

141. Archived: Final Evidence Summary: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
     May 29, 2012 - This review includes health outcomes (such as fractures) rather than intermediate outcomes (such as bone … trial 58 compared an ultra-low dose of transdermal estradiol (0.014 mg/d) with placebo to evaluate bone … history of falls, personal or family history of fracture, calcium intake, previous hormone therapy, bone … Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. … placebo (208 vs. 209 participants) for 2 y Postmenopausal women without hysterectomies who had normal bone

142. Final Research Plan: Vitamin D Deficiency: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan37/vitamin-d-deficiency-screening
     March 24, 2014 - is the effect of vitamin D (with or without calcium) on intermediate outcomes (e.g., blood pressure, bone

143. Archived: Final Research Plan: Vitamin D Deficiency: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan37/vitamin-d-deficiency-screening-november-2014
     March 24, 2014 - is the effect of vitamin D (with or without calcium) on intermediate outcomes (e.g., blood pressure, bone

144. Evidence Summary: Thyroid Dysfunction: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary7/thyroid-dysfunction-screening
     October 28, 2014 - increased risk for all-cause and coronary heart disease mortality, atrial fibrillation, 9 and decreased bone … cognitive function; and harms, including those related to overreplacement (such as negative effects on bone … Intermediate outcomes were effects on lipid levels, blood pressure, weight change, and bone mineral density … Trials found no clear benefits of treatment of subclinical hypothyroidism on blood pressure, bone mineral … Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism

145. 6Y7Rjecz Klegpj4Qqxmbc (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6Y7RjECz_KLeGpJ4qQxmBC
     January 01, 2015 - risk for all- cause and coronary heart disease mortality, atrial fibril- lation (9), and decreased bone … cognitive func- tion; and harms, including those related to overre- placement (such as negative effects on bone … Intermediate outcomes were effects on lipid levels, blood pressure, weight change, and bone mineral density … Trials found no clear benefits of treatment of subclinical hypothyroidism on blood pressure, bone mineral … Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism

146. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
     June 20, 2019 - Bone. 2003;33(4):522-532. doi:10.1016/S8756-3282(03) 00241-2 68. … J Bone Miner Res. 2004;19(8): 1270-1275. doi:10.1359/JBMR.040406 70. … J Bone Miner Res. 2005;20(9):1514- 1524. doi:10.1359/JBMR.050509 75. … J Bone Miner Res. 2008;23(1):112-120. doi:10.1359/jbmr.070904 78. … in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial [

147. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the USPSTF Recommendations (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/G7CCbu64mf-nCynBkHbFLA
     July 01, 2012 - This review includes health outcomes (such as fractures) rather than intermediate outcomes (such as bone … trial (58) compared an ultra-low dose of transdermal estradiol (0.014 mg/d) with placebo to evaluate bone … his- tory of falls, personal or family history of fracture, calcium intake, previous hormone therapy, bone … Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. … placebo (208 vs. 209 participants) for 2 y Postmenopausal women without hysterectomies who had normal bone

148. Archived: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
     June 11, 2019 - associated with significant adverse events in adolescents but may be associated with slightly less bone … differences between PrEP and placebo. 44 , 46-50 Tenofovir disoproxil fumarate exposure is associated with bone … Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized … Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind … Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure

149. Evidence Gaps Research Taxonomy Table: Screening for Osteoporosis to Prevent Fractures (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kHT3WGUaG2wTz2pF_ke7bn
     January 14, 2025 - Abbreviations: BMD=bone mineral density; DXA=dual-energy X-ray absorptiometry; FDA=U.S.

150. Screening for Elevated Blood Lead Levels in Children and Pregnant Women (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZyMe6J3wKnVkNuFP2p3W_5
     December 15, 2006 - Most lead is stored in bone. … High bone lead levels can be present with normal blood lead levels, so that blood lead levels often

151. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/v1-breast-cancer-medications-for-risk-reduction--s
     May 06, 2002 - Both the BCPT and MORE trials also examined the impact of these drugs on bone fractures. … Bone mass and breast cancer risk in older women: differences by stage at diagnosis. … Bone mass and the risk of breast cancer among postmenopausal women. … than breast cancer, women with particularly increased (or decreased) risk of thromboembolic events, bone … Possible benefits from tamoxifen or raloxifene chemoprevention include reduced risk of heart disease and bone

152. Chemo and Couns/2nd instal (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
     July 01, 2002 - Both the BCPT and MORE trials also examined the impact of these drugs on bone fractures. … Bone mass and breast cancer risk in older women: differences by stage at diagnosis. … Bone mass and the risk of breast cancer among postmenopausal women. … than breast cancer, women with particularly increased (or decreased) risk of thromboembolic events, bone … Possible benefits from tamoxifen or raloxifene chemoprevention include reduced risk of heart disease and bone

153. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
     May 06, 2002 - Both the BCPT and MORE trials also examined the impact of these drugs on bone fractures. … Bone mass and breast cancer risk in older women: differences by stage at diagnosis. … Bone mass and the risk of breast cancer among postmenopausal women. … than breast cancer, women with particularly increased (or decreased) risk of thromboembolic events, bone … Possible benefits from tamoxifen or raloxifene chemoprevention include reduced risk of heart disease and bone

154. Evidence Gaps Research Taxonomy Table: Research Gaps for Screening and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/xBhJwGtUHqmEvPg_gKk4nw
     January 01, 2001 - , quality of life, functional status, or morbidity KQ 5: Dental fluorosis, tooth staining, bone

155. Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
     June 11, 2019 - associated with significant adverse events in adolescents but may be associated with slightly less bone … ferences between PrEP and placebo.44,46-50 Tenofovir disoproxil fumarate exposure is associated with bone … Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized … Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind … Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure

156. Archived: Lead Levels in Childhood and Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lead-levels-in-childhood-and-pregnancy-screening-2006
     December 15, 2006 - Most lead is stored in bone. … High bone lead levels can be present with normal blood lead levels, so that blood lead levels often

157. Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KFZpoMBYuoo8TRW6nhRev8
     October 23, 2023 - intracellular drug levels at lower tenofovir se- rum levels, potentially increasing effectiveness and bone … 2694) vs 17% (453/2693) Nausea: 4.2% (114/2694) vs 4.6% (123/2693) in primary (interim) analysis Hip bone … +0.6% vs –1.0% in persons aged ≥25 y (P < .001) and +1.2% vs –1.7% in persons <25 y (P = .04) Spine bone … associated with increased efficacy.42,54 TAF/FTC was associated with positive short- term effects on bone … between newer vs older PrEP regimens in inter- mediate outcomes (weight gain, lipid parameters, or bone

158. Final Research Plan: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-adults-interventions
     March 31, 2016 - medical treatment, inducement of eating disorder, nausea or other gastrointestinal effects, reduced bone

159. Archived: Syphilis Infection in Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening-2009
     May 15, 2009 - Importance Untreated syphilis during pregnancy is associated with stillbirth, neonatal death, bone

160. Draft Recommendation: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     May 04, 2021 - caused by excessive doses of vitamins; for example, moderate doses of vitamin A supplements may reduce bone … vitamin and mineral supplements to their patients for a variety of reasons such as overall health, bone